ZYBERNO
Stock Report
Updated Sep 1, 2026

EUDA Health Holdings Ltd (EUDA)

Healthcare • NASDAQ

$13.55

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
7.0/100
POOR BUSINESS
EUDA Health Holdings Ltd (EUDA) scores 7/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-41.1%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

EUDA Health Holdings Ltd (EUDA) stock report — Zyberno Score 7/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:13.55
Market Cap:$33.75M

Valuation Multiples (2)

P/S Ratio:4.95x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$33.66M

Price Action & Momentum (1)

% of 52-Week High:15.8%
B. Profitability Assessment

Return Metrics (4)

ROA:-37.8%
Reinvestment Rate:1.1%
Fundamental Growth Rate (g):-0.5%

Margin Analysis (1)

Ebitda Margin:-201.9%

Yield Metrics (2)

Earnings Yield:-$999.00
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:0.79x
Quick Ratio:0.79x
Cash Ratio:0.01x

Leverage Analysis (1)

Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-10.84x
Times Interest Earned:-10.84

Capital Structure (4)

Working Capital:-6,530,198.00
Cash And Cash Equivalents:265,852.00
Long Term Debt:$71.72K
Net Debt:-$85.19K
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$6.82M
Cost Of Revenue Ttm:$3.83M

Profitability Breakdown (2)

$2.99M-$13.81M

Bottom Line Performance (3)

-$27.07M
Income Before Tax:-$2.41M
Ebitda Ttm:-13,770,366.00

Operating Expenses (5)

Operating Expenses:2,380,378.00
R And D Expense:2,946.00
Sga Expense:1,975,607.00
Income Tax Expense:$985.00
Interest Expense:228,624.00

Expense Ratios (3)

R And D To Revenue Percentage:0.2%
Sga To Revenue Percentage:116.3%
Ebitda Margin:-201.9%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$25.48M
Current Assets:$24.80M
Ppe Net:27,892.00
Goodwill:0.00
Intangible Assets:$161.43K

Liability Structure (4)

Total Liabilities:31,417,343.00
Current Liabilities:31,332,300.00
Long Term Debt:$71.72K
Short Term Debt:$108.94K

Equity & Capital (3)

Equity:-$5.94M
Retained Earnings:-$27.12M
Common Stock:21,308,969.00

Working Capital Items (3)

Accounts Receivable:1,585,378.00
Inventory:2,844.00
Accounts Payable:1,836,497.00

Special Items (2)

Contract Liabilities:522,030.00
Stock Based Compensation:0.00
C. Cash Flow Analysis

Operating Activities (2)

-$2.01M-$2.50M

Investment Activities (1)

Investing Cash Flow:-$29.33K

Financing Activities (3)

Financing Cash Flow:$525.33K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:38,549.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (1)

Earnings Per Share Ttm:-$10.87

Revenue & Cash Per Share (2)

Sales Per Share Ttm:2.74
Operating Cash Flow Per Share:-$0.97

Book Value & Capital (2)

Book Value Per Share:-$2.38
Cash Per Share:0.11

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.10x
Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:4.30x
Days Sales Outstanding Ttm:84.84

Inventory Management (2)

Inventory Turnover Ttm:1,345.80x
Days Inventory Outstanding Ttm:0.27

Payables & Cash Cycle (2)

Days Payable Outstanding:175.13
Cash Conversion Cycle:-90.02
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:20.00
Quality Score:20.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:1.1%
Fundamental Growth Rate (g):-0.5%
B. Log-Linear Regression Growth Analysis
C. Company Profile & Context

Corporate Information (6)

Symbol:EUDA
Company Name:EUDA Health Holdings Ltd
Sector:Healthcare
Industry:Healthcare Services
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:medium
Volume Category:N/A

Share Structure (3)

Shares Outstanding:2.49M
Shares Outstanding Basic:20.19M
Shares Outstanding Diluted:20.19M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 03:32:03 UTC
Data Timestamp:2026-08-20T11:34:06.873615
Scroll to Top